The U.S. Food and Drug Administration issued a Feb. 2015 Guidance for Industry titled, “Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities,” that is being distributed for comment purposes only.
E-BOOK SPECIAL REPORT
44 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative package designs of the past year.
Global healthcare company Sanofi and biopharma-ceutical company MannKind Corp. announced that Afrezza (insulin human) Inhalation Powder is now available by prescription in U.S. retail pharmacies nationwide.
The Patient Protection and Affordable Care Act, faster FDA product approvals, and millions of previously uninsured people potentially entering the patient pool expected to help drive future pharmaceutical growth.
Although there are differences between the medical device Unique Device Identification (UDI) regulation and the Pharmaceutical Drug Supply Chain Security Act (DSCSA), Videojet Technologies’ Tim Kearns finds many common aspects across both.